Mr. Henderson notes Paul M. Romer’s ideas relating the structure of incentives to innovation using the profoundly crucial role patent policy has played in pharmaceutical innovation. But in the 21st century governments have countered the otherwise positive impact of patents with all manner of pharmaceutical price controls.

Dementia Innovation Readiness Index Issues Call-to-Action for Argentina, Brazil, China, India, and Saudi Arabia to Prioritize National Plans, Earlier Detection and Diagnosis, Quality Care, and Awareness Campaigns (Chicago – July 27, 2018) – Today, the Global Coalition on Aging (GCOA) and Alzheimer’s Disease International (ADI) will present findings from the 2018 Dementia Innovation Readiness Index…

New guidance provides clarity on endpoints, will help spur pharmaceutical innovation for Alzheimer’s treatments NEW YORK, NY (17 May 2018) – The Global Coalition on Aging (GCOA) today submitted comments to the U.S. Food & Drug Administration (FDA) supporting the administration’s new regulatory guidance document on early Alzheimer’s disease and calling for similar updates for related dementias….

The unique one-day event brought focus on active and healthy ageing ahead of Slush, Europe’s largest startup conference HELSINKI, FINLAND (November 29, 2017) – On November 28, the second-annual Digital Silver Forum convened nearly 400 leaders from global businesses, startups, NGOs, governments, and policymaking organizations for a day-long event in Helsinki to connect digital innovation…

Paper highlights research showing that remote care yields benefits across the healthcare continuum, including improved quality of life and reduced costs BOSTON (October 25, 2017) – The Global Coalition on Aging (GCOA) today released a position paper calling for greater attention to remote care delivery (RCD) as a new standard of care for the 21st…